Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
BHV BlackRock Virginia Municipal Bond Trust
JNJ Johnson & Johnson
TRQ Turquoise Hill Resources Ltd
STAA STAAR Surgical Co
PRPL Purple Innovation Inc
INTC Intel Corp
PSB PS Business Parks Inc
GWRE Guidewire Software Inc
UYM.TC ProShares Ultra Basic Materials ETF
Go

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Closing Price
$24.90
Day's Change
0.03 (0.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.26
Day's Low
24.71
Volume
(Below Average)
Volume:
51,007,411

10-day average volume:
60,060,344
51,007,411

Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings Limited

6:39 pm ET August 26, 2020 (PR Newswire) Print

Cancer Genetics, Inc. (NASDAQ: CGIX)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of CGIX with StemoniX, Inc.

If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Jernigan Capital, Inc. (NYSE: JCAP, JCAP-PB)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of JCAP to an affiliate of NexPoint Advisors, L.P. for $17.30 per share.

If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of MNTA to JNJ for $52.50 per share in cash.

If you are a MNTA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

NTN Buzztime, Inc. (NYSE: NTN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of NTN with Brooklyn ImmunoTherapeutics LLC.

If you are a NTN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Principia Biopharma Inc. (NASDAQ: PRNB)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of PRNB to Sanofi for $100 per share.

If you are a PRNB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of SBPH to F-star Therapeutics, Limited.

If you are a SPBH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Varian Medical Systems, Inc. (NYSE: VAR)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of VAR to Siemens Healthineers AG.

If you are a VAR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Yintech Investment Holdings Limited (NASDAQ: YIN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of YIN to members of YIN management.

If you are a YIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.(C) 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.Lifshitz Law Firm, P.C. Phone: 516-493-9780Facsimile: 516-280-7376Email: info@jlclasslaw.com

https://c212.net/c/img/favicon.png?sn=DC07890&sd=2020-08-26

View original content:http://www.prnewswire.com/news-releases/lifshitz-law-firm-pc-announces-investigation-of-cancer-genetics-inc-jernigan-capital-inc-momenta-pharmaceuticals-inc-ntn-buzztime-inc-principia-biopharma-inc-spring-bank-pharmaceuticals-inc-varian-medical-syste-301119276.html

SOURCE Lifshitz & Miller Law Firm

https://rt.prnewswire.com/rt.gif?NewsItemId=DC07890&Transmission_Id=202008261839PR_NEWS_USPR_____DC07890&DateId=20200826

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.